Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-11-002085
Filing Date
2011-05-26
Accepted
2011-05-26 20:47:27
Documents
2
Period of Report
2011-05-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 7743
2 POWER OF ATTORNEY ex24.htm EX-24 7564
  Complete submission text file 0000950103-11-002085.txt   16647
Mailing Address SOLAZYME, INC. 225 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
ARBIGE MICHAEL V (Reporting) CIK: 0001225608 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35189 | Film No.: 11875878

Mailing Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080
Business Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080 650-780-4777
SOLAZYME INC (Issuer) CIK: 0001311230 (see all company filings)

EIN.: 331077078 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals